Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
First Edition BOGP (0)
Germany (2)
Education (awareness, health promotion)
Neurology/Parkinson's Disease (1)
Regulatory Body (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase I